Skip Navigation

NCI-COG Pediatric MATCH Molecular Analysis for Therapy Choice - Phase 2 Subprotocol of AG-120 Ivosidenib in Patients with Tumors Harboring IDH1 Mutations

Brief Summary

Type:
Multiple Sites (Solid Tumors)

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT04195555

Study #:
CMH - APEC1621K

Start Date:
Jun 11, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04195555

View Complete Trial Details & Eligibility at ClinicalTrials.gov